Shares of Infosys Ltd ADR (NYSE:INFY), surged 0.05% to $19.01, during its last trading session.
The stock saw its price movement on below-normal volume, as 3.82 million shares changed hands when contrast with its average daily volume of 4.31 million shares, with a year-to-date performance of 22.63%.
Infosys Limited (NSE, BSE, NYSE: INFY), a global leader in consulting, technology, outsourcing and next-generation services, will declare the results for its second quarter ended September 30, 2015 on Monday, October 12, 2015 at 8:45 a.m. Indian Standard Time (IST) ( 11:15 p.m. US ET on October 11, 2015 ; 08:15 p.m. PST on October 11, 2015 ; 4:15 a.m. London time; 11:15 a.m. Singapore / Hong Kong time). The results will also be accessible on http://www.infosys.com.
Infosys Limited, together with its auxiliaries, provides business consulting, technology, engineering, and outsourcing services in North America, Europe, India, and internationally.
At the end of Wednesday’s trade, Shares of CubeSmart (NYSE:CUBE), inclined 0.88% to $27.60. It traded in a range of $27.26 and $27.60, exchanging hands with 3.79 shares.
The stock is down 54.56% in this year through last close. In the trailing twelve months, net profit margin of the company was 7.30% while gross profit margin was 65.00%.
CubeSmart (CUBE) declared that the Company will release financial results for the three and nine month periods ended September 30, 2015 after the market close on Thursday, November 5, 2015. An accompanying conference call will be held at 11:00 a.m. ET on Friday, November 6, 2015.
CubeSmart is an equity real estate investment trust. The firm invests in the real estate markets of the United States.
Shares of Cyberonics, Inc. (NASDAQ:CYBX), ended its last trade with 0.60% gain, and closed at $63.79.
The stock, after recent close, is 0.18% above their SMA 50 and -2.62% from SMA20 and is 2.94% above than SMA200. The company has 5.52 value in price to sale ratio while price to book ratio was recorded as -5.66. It beta stands at 0.74.
Cyberonics, Inc., together with its auxiliaries, designs, develops, markets, and sells medical devices to hospitals and ambulatory surgery centers. It offers vagus nerve stimulation therapy system, an implantable device that provides neuromodulation therapy for the treatment of drug-resistant epilepsy and treatment-resistant depression; and VITARIA System, an implantable device that offers a form of neuromodulation therapy for the treatment of chronic heart failure.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
